Clindamycin Phosphate Topical Solution USP — Class III drug recall D-1139-2023
Terminated recall by Contract Pharmaceuticals Limited Canada, reported 2023-09-06, distributed nationwide. Defective Container: slow leakage under the cap
| Recall number | D-1139-2023 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Contract Pharmaceuticals Limited Canada, Mississauga, N/A, Canada |
| Recall initiated | 2023-08-23 |
| Classified | 2023-08-29 |
| Reported by FDA | 2023-09-06 |
| Terminated | 2025-08-06 |
| Distributed | Nationwide (US) |
| Quantity | 11,350 bottles |
| Reason classes | packaging |
| NDC | 71428-0003-60 |
| Lot numbers | 118920 |
| Expiration dates | 2024-01-20 |
Product
Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60
Reason for recall
Defective Container: slow leakage under the cap
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1139-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.